Wockhardt receives US FDA approval for Olopatadine HCI
Olopatadine HCI, eye drop to treat ophthalmic allergies, is a generic version of Patanol
Author
Domino Printech India to launch Ax-Series
The new range of continuous ink jet will reset customer expectations of productivity, quality and cost of ownership
Dr Tedros Adhanom Ghebreyesus takes office as Director-General, WHO
The Director-General is WHO's chief technical and administrative officer and oversees the policy for the Organisation's…
Unichem gets EIR from US FDA for Goa plant
The receipt indicates successful closure of the inspection and queries raised during the audit
Zydus Cadila gets US FDA nod to market anti-obesity drug
The drug will be produced at the group’s formulations manufacturing facility at Moraiya in Ahmedabad
Researchers refute textbook knowledge in molecular interactions
The discovery could have many potential implications for the delivery of pharmaceutical molecules in cells
Sayre Therapeutics in license and distribution agreement with Navidea Biopharmaceuticals
To develop and commercialise Tc 99m tilmanocept in India
NPPA revised ceiling price of 761 drugs under GST rates
761 drugs price declined as NPPA revised the ceiling piece exclusive of applicable GST rates
Cadila gets board approval to raise Rs 18,500 cr
Board also approved issuing foreign currency bonds/ foreign currency convertible bonds
Zydus Cadila to market oxybutynin chloride tablets
Oxybutynin is used to treat overactive bladder and urinary incontinence